Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with ...

Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in ...

The government agency says X no longer suits its communication needs.

Veeva’s vice president of commercial strategy discusses how streamlining their processes with a single goal in mind can ...

Campaign encourages the use of low-dose aspirin to help reduce the risk of preeclampsia and the complications that come with ...

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD).

Cary Claiborne, CEO, Adial Pharmaceuticals, discusses AD04’s development timeline and next steps towards approval for alcohol ...

Trial findings show long-term recurrence-free survival in patients with low-grade upper tract urothelial cancer treated with ...

Panel participants share an optimistic outlook for integrating new innovations, tacking community-level challenges, and more.

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...